Prot# A4091025: A Phase 3, Multi-Center, Randomized, Double-Blind, Controlled Study of the Long-Term Analgesic Efficacy and Safety of Tanezumab Alone or in Combination with Non-Steroidal Anti-Inflammatory Drugs (Nsaids) versus Nsaids Alone in Patients wi